
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
Cooper Companies reported an operating margin of 26.1%, which reflects a year-over-year increase of 60 basis points and surpasses consensus expectations, underscoring the company's operational efficiency. The gross margin also demonstrated strength, rising to 67.3%, attributed to improved product mix and favorable foreign exchange impacts, reinforcing the company's solid financial health. Additionally, management anticipates the global contact lens market will expand at a rate of 4-6% through 2026, with CooperVision expected to maintain at least this level of growth, while CooperSurgical is poised for increased market share and recovery in fertility cycle volumes, suggesting a favorable outlook for overall revenue and free cash flow generation.
Bears say
Cooper Companies is experiencing significant challenges, as evidenced by a 10% year-over-year decline in PARAGARD sales, attributed to forward buying ahead of an upcoming price increase. The company's organic revenue growth expectations for FY25 have been lowered from 4.0% to 3.25%, reflecting an overall weakness in both fertility and contact lens segments, while its Sphere/Other revenue declined by -1% year-over-year. Additionally, projected growth for the CooperVision segment is at its weakest level since the Great Recession, leading to an after-hours decline in shares by 12% amidst already depressed valuation levels.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares